Annual Drug Patent Expirations for FERRIPROX
Ferriprox is a drug marketed by Chiesi and is included in three NDAs. It is available from two suppliers. There are two patents protecting this drug and one Paragraph IV challenge.
Drug patent litigation for FERRIPROX.
This drug has thirty-seven patent family members in twenty-five countries.
The generic ingredient in FERRIPROX is deferiprone. Two suppliers are listed for this compound. Additional details are available on the deferiprone profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
